http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113817063-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113817063-B |
| titleOfInvention | Anti-human abnormal prothrombin antibody and application thereof |
| abstract | The invention belongs to the field of antibodies, and particularly relates to an anti-human abnormal prothrombin antibody and application of the antibody in preparation of a hepatocellular carcinoma detection kit. The anti-human abnormal prothrombin antibody can be specifically combined with the human abnormal prothrombin, can further avoid the interference from prothrombin in serum or plasma from the raw material level, can further avoid the interference from abnormal prothrombin in other species in an animal serum product, avoids related risks from the source, reduces the difficulty of reagent development, and has good application prospect. |
| priorityDate | 2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 265.